Oncology White Paper
Every year, Bryan, Garnier & Co hosts a special “Oncology Day” with the Institute Curie in Paris. Attended by leading experts in cancer research and treatment as well as strategic investors and fund managers, the latest thinking and trends in the field of immune-oncology are discussed.
The growing importance of biological and immunology therapies is expected to drive the global market for immuno-oncology drugs to over $30 billion by 2020. To help investors understand the key trends, we have captured these insights in a new report.